204 related articles for article (PubMed ID: 11862416)
1. Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen system.
Wikstrand CJ; Cole VR; Crotty LE; Sampson JH; Bigner DD
Cancer Immunol Immunother; 2002 Feb; 50(12):639-52. PubMed ID: 11862416
[TBL] [Abstract][Full Text] [Related]
2. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA
Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764
[TBL] [Abstract][Full Text] [Related]
3. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
[TBL] [Abstract][Full Text] [Related]
4. Idiotypic analysis of anti-I-Ak monoclonal antibodies. III. T- and B-cell responses to anti-Ia idiotopes are not modulated by syngeneic anti-idiotypic monoclonal antibodies.
Phillips ML; Delovitch TL
Cell Immunol; 1985 Dec; 96(2):363-75. PubMed ID: 3879805
[TBL] [Abstract][Full Text] [Related]
5. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
Irvine K; Schlom J
Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
[TBL] [Abstract][Full Text] [Related]
6. Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII).
Klausz K; Berger S; Lammerts van Bueren JJ; Derer S; Lohse S; Dechant M; van de Winkel JG; Peipp M; Parren PW; Valerius T
Cancer Sci; 2011 Oct; 102(10):1761-8. PubMed ID: 21718386
[TBL] [Abstract][Full Text] [Related]
7. Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall cell lung cancer patients, induce tumor cell death by an oncosis-like mechanism.
Hernández AM; Rodríguez N; González JE; Reyes E; Rondón T; Griñán T; Macías A; Alfonso S; Vázquez AM; Pérez R
J Immunol; 2011 Mar; 186(6):3735-44. PubMed ID: 21300821
[TBL] [Abstract][Full Text] [Related]
8. Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
Birebent B; Koido T; Mitchell E; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai E; Herlyn D
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R27-33. PubMed ID: 11768621
[TBL] [Abstract][Full Text] [Related]
9. Generation of Her-2/neu vaccine utilizing idiotypic network cascade.
Pal S; Saha A; Mohanty K; Mallick P; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Cancer Biol Ther; 2007 Dec; 6(12):1916-25. PubMed ID: 18059165
[TBL] [Abstract][Full Text] [Related]
10. Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.
Pohl C; Renner C; Schwonzen M; Sieber M; Lorenz P; Pfreundschuh M; Diehl V
Int J Cancer; 1992 Apr; 50(6):958-67. PubMed ID: 1313400
[TBL] [Abstract][Full Text] [Related]
11. Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes.
Bhattacharya-Chatterjee M; Pride MW; Seon BK; Kohler H
J Immunol; 1987 Aug; 139(4):1354-60. PubMed ID: 3497200
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the anti-idiotypic responses generated by antibodies to a protein and a hapten: a common interspecies idiotype on antibodies against human albumin induces an idiotypic network in rabbits.
Comacchio RM; Bradley J; Hohmann AW
Immunol Cell Biol; 1996 Feb; 74(1):72-80. PubMed ID: 8934657
[TBL] [Abstract][Full Text] [Related]
13. Antigen dose escalation study of a VEGF-based therapeutic cancer vaccine in non human primates.
Morera Y; Bequet-Romero M; Ayala M; Pérez PP; Castro J; Sánchez J; Alba JS; Ancízar J; Cosme K; Gavilondo JV
Vaccine; 2012 Jan; 30(2):368-77. PubMed ID: 22075086
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
15. Characterization of antibodies to idiotypic determinants of monoclonal anti-sperm antibodies.
Carron CP; Jarvis HW; Saling PM
Biol Reprod; 1988 Jun; 38(5):1093-103. PubMed ID: 2457396
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H
J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815
[TBL] [Abstract][Full Text] [Related]
17. Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.
Baral R; Sherrat A; Das R; Foon KA; Bhattacharya-Chatterjee M
Int J Cancer; 2001 Apr; 92(1):88-95. PubMed ID: 11279611
[TBL] [Abstract][Full Text] [Related]
18. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
Herlyn D; Ross AH; Iliopoulos D; Koprowski H
Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
[TBL] [Abstract][Full Text] [Related]
19. Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3).
Bhattacharya-Chatterjee M; Chatterjee SK; Vasile S; Seon BK; Kohler H
J Immunol; 1988 Aug; 141(4):1398-403. PubMed ID: 2899603
[TBL] [Abstract][Full Text] [Related]
20. Intracellular tumor-associated antigens represent effective targets for passive immunotherapy.
Noguchi T; Kato T; Wang L; Maeda Y; Ikeda H; Sato E; Knuth A; Gnjatic S; Ritter G; Sakaguchi S; Old LJ; Shiku H; Nishikawa H
Cancer Res; 2012 Apr; 72(7):1672-82. PubMed ID: 22318866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
